Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers

Fig. 3

Effects of TMPRSS2 overexpression on HLA class I expression, the antigen presentation machinery (APM) and interferon (IFN) signaling in TMPRSS2-transfected cells and their influence on natural killer (NK) cell function. A: Flow cytometry was used to assess HLA-I surface expression in TMPRSS2 transfectants and mock control MCF-7 and EA.Hy926 cells as described in the Methods. The results are displayed as a histograms with the mean fluorescence intensity (MFI) of HLA-ABC (n = 3). B: The expression of major HLA-I APM components in TMPRSS2 transfectants was evaluated using qPCR as described in the Methods. C: The cytotoxic activity of NK cells from three different donors against TMPRSS2low and TMPRSS2high MCF-7 cells was evaluated using a CD107a degranulation assay. Data are shown as mean ± SE of CD107a degranulation upon normalization to the mock-transfected cells. D: TMPRSS2 transfectants were examined by qPCR for the expression of components of the IFN as well as JAK-STAT signaling pathways. The results are shown as an x-fold induction in the expression of these signaling components in TMPRSS2 transfectants relative to mock controls. E: Representative Western blot analyses of TMPRSS2high and mock-transfected using antibodies directed against IRF1, IRF27, STAT1, pSTAT1 and STAT2. Staining with an anti-ACTB antibody served as a loading control

Back to article page